Supra-regional referral centre model for management of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in the UK-Reference-Cited by-同舟云学术

Supra-regional referral centre model for management of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in the UK

Published:2024-03 Issue: Volume:90 Page:73-75
ISSN:1748-6815
Container-title:Journal of Plastic, Reconstructive & Aesthetic Surgery
language:en
Short-container-title:Journal of Plastic, Reconstructive & Aesthetic Surgery

Author:

McKean Andrew R.,Attygalle Ayoma D.,El-Sharkawi Dima^ORCID,O’Connell Rachel L.,Sharma Bhupinder,Wotherspoon Andrew,Tasoulis Marios-Konstantinos^ORCID,Khan Aadil A.

Funder

National Institute for Health and Care Research

Institute of Cancer Research

Publisher

Elsevier BV

Reference5 articles.

1. A spectrum of disease: Breast implant-associated anaplastic large cell lymphoma, atypicals, and other implant associations;Fracol;Clin Plast Surg,2023

2. Medicines and Healthcare products Regulatory Agency (MHRA). Guidance: Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). 2023. Available at: 〈https://www.gov.uk/guidance/breast-implants-and-anaplastic-large-cell-lymphoma-alcl#full-publication-update-history〉. Accessed 20/01/24.

3. Incidence and outcome of breast sarcomas in England (2013-2018): An analysis from the National Cancer Registration and Analysis Service;Ahmed;Eu J Cancer,2022

4. Oncological outcomes after multidisciplinary management of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL);O’Connell;Ann Surg Oncol,2023

5. National Comprehensive Cancer Network (NCCN®). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).T-cell Lymphomas Version 1. 2023. Available at: 〈https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf〉. Accessed: 20/01/24.